| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Physiology and Obstetrics and Gynecology (V.L.C., T.G.T., S.J.L., J.R.G.C.), University of Toronto, Toronto, Ontario, Canada M5S 1A8; Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto, Ontario, Canada, M5G 1X5; and the Medical Research Council Group in Fetal and Neonatal Health and Development, the Medical Research Council Group in Development and Fetal Health, and the Department of Obstetrics and Gynecology (J.F.T., A.J.T., I.T.C.), University of Glasgow, Glasgow, Scotland G3 8SJ
Address all correspondence and requests for reprints to: Dr. John Challis, Department of Physiology, University of Toronto, 1 Kings College Circle, Toronto, Ontario, Canada M5S 1A8.
CRH and POMC-derived peptides are produced at a number of intrauterine
sites in both the nonpregnant and pregnant states. It is hypothesized
that CRH and POMC-derived peptides may be produced locally by the
uterus to modulate myometrial contractility. This study has examined
the distribution of these peptides in human uterine tissue during the
ovulatory cycle and pregnancy. The immunoperoxidase staining method was
used to localize CRH and POMC-derived peptides: ACTH, ß-endorphin,
and
MSH. Immunoreactive (IR-) CRH and IR-POMC-derived peptides,
ß-endorphin and
MSH, were observed in the myometrial smooth
muscle, vascular smooth muscle, endometrial glandular epithelium, and
luminal epithelium of the nonpregnant uterus (n = 17). Staining
for IR-CRH did not change during the cycle from the proliferative
(n = 8) to the secretory phases (n = 9). Conversely, staining
for IR-ß-endorphin and IR-
MSH was only observed during the
secretory phase of the cycle (n = 9). In uterine tissue obtained
from pregnant women (n = 20) IR-CRH was present in the myometrial
smooth muscle, vascular smooth muscle, decidua, and glandular
epithelium. IR-POMC-derived peptides were not detectable at any uterine
site during pregnancy (n = 20). IR-CRH was measurable in
myometrial extracts collected from pregnant women undergoing cesarean
section (20.9 ± 3.8 ng/g wet wt; n = 7) and from nonpregnant
premenopausal women undergoing hysterectomy (7.7 ± 2.1 ng/g wet
wt; n = 6). IR-CRH concentrations significantly increased with
pregnancy. Levels of messenger ribonucleic acid encoding for CRH were
examined in nonpregnant (n = 4) and pregnant (n = 10)
myometrial smooth muscle and were also significantly increased with
pregnancy. This study has demonstrated that levels of CRH and POMC
peptide in human uterine tissue change with pregnancy and that CRH is
produced locally by myometrial smooth muscle cells. These studies are
consistent with the possibility that the CRH peptide has an
autocrine/paracrine activity during pregnancy and labor that may be
related to the modulation of myometrial contractility.
This article has been cited by other articles:
![]() |
T. M Lindstrom and P. R Bennett The role of nuclear factor kappa B in human labour Reproduction, November 1, 2005; 130(5): 569 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Matejec, A. Schulz, H.-W. Harbach, H. Uhlich, G. Hempelmann, and H. Teschemacher Effects of tourniquet-induced ischemia on the release of proopiomelanocortin derivatives determined in peripheral blood plasma J Appl Physiol, September 1, 2004; 97(3): 1040 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sehringer, W. R. Schäfer, B. Wetzka, W. R. Deppert, R. Brunner-Spahr, E. Benedek, and H. P. Zahradnik Formation of Proinflammatory Cytokines in Human Term Myometrium Is Stimulated by Lipopolysaccharide But Not by Corticotropin-Releasing Hormone J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4859 - 4865. [Abstract] [Full Text] |
||||
![]() |
D. K. Grammatopoulos, H. S. Randeva, M. A. Levine, E. S. Katsanou, and E. W. Hillhouse Urocortin, but Not Corticotropin-Releasing Hormone (CRH), Activates the Mitogen-Activated Protein Kinase Signal Transduction Pathway in Human Pregnant Myometrium: An Effect Mediated via R1{{alpha}} and R2{beta} CRH Receptor Subtypes and Stimulation of Gq-Proteins Mol. Endocrinol., December 1, 2000; 14(12): 2076 - 2091. [Abstract] [Full Text] |
||||
![]() |
A. Slominski, J. Wortsman, T. Luger, R. Paus, and S. Solomon Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress Physiol Rev, July 1, 2000; 80(3): 979 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.S. Nandhra and R.J. Carson {beta}-endorphin inhibits the production of interleukin-8 by human chorio-decidual cells in culture Mol. Hum. Reprod., June 1, 2000; 6(6): 555 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zoumakis, A.N. Margioris, C. Stournaras, E. Dermitzaki, E. Angelakis, A. Makrigiannakis, E. Koumantakis, and A. Gravanis Corticotrophin-releasing hormone (CRH) interacts with inflammatory prostaglandins and interleukins and affects the decidualization of human endometrial stroma Mol. Hum. Reprod., April 1, 2000; 6(4): 344 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Grammatopoulos and E. W. Hillhouse Basal and Interleukin-1{beta}-Stimulated Prostaglandin Production from Cultured Human Myometrial Cells: Differential Regulation by Corticotropin- Releasing Hormone J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2204 - 2211. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |